TCM

Tybourne Capital Management Portfolio holdings

AUM $34.5M
1-Year Est. Return 2.7%
This Quarter Est. Return
1 Year Est. Return
-2.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$34.5M
AUM Growth
+$11M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

1
+$4.2M
2
+$2.9M
3
+$2.15M
4
MBUU icon
Malibu Boats
MBUU
+$2.09M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$912K

Top Sells

1
+$7.18M

Sector Composition

1 Healthcare 93.95%
2 Consumer Discretionary 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBRX icon
1
Forte Biosciences
FBRX
$138M
$10.2M 29.45%
786,647
+166,666
TSHA icon
2
Taysha Gene Therapies
TSHA
$1.25B
$9.46M 27.39%
4,095,000
+395,000
BCYC
3
Bicycle Therapeutics
BCYC
$568M
$6.91M 20%
993,743
+417,400
ALMS
4
Alumis Inc
ALMS
$485M
$4.2M 12.15%
+1,399,250
MBUU icon
5
Malibu Boats
MBUU
$598M
$2.09M 6.05%
+66,705
ZNTL icon
6
Zentalis Pharmaceuticals
ZNTL
$113M
$1.71M 4.96%
1,478,152
+516,666
SLRN
7
DELISTED
ACELYRIN
SLRN
– –
-2,906,629